DoD Gulf War Illness Investigator Initiated Research Award | Apply Online

Opportunity Summary:

The DoD Gulf War Illness Investigator Initiated Research Award (IIRA) is a Department of the Army, U.S. Army Medical Research Acquisition Activity (USAMRAA) funding mechanism under the Gulf War Illness Research Program (GWIRP) meant to push forward new, investigator-driven ideas that can establish proof of principle and set up larger follow-on studies. First offered in FY2006, the program had received 208 applications with 57 recommended for funding up to the time of this FY2015 announcement, signaling that it is competitive but also established. The central requirement is that proposals stay tightly focused on Gulf War Veterans affected by Gulf War Illness (GWI), and that the Principal Investigator clearly explains how the work will meaningfully impact GWI understanding, diagnosis, or future treatment development.

A key feature of this award is its emphasis on the complex, chronic, multisymptom nature of GWI. Funded projects can span basic through clinical research, but the overall aim is practical: improve how GWI is defined and diagnosed, better characterize symptom patterns, and deepen understanding of the underlying biology (pathobiology). A major priority is identification of objective measures, especially biomarkers, that can distinguish healthy Veterans from those with GWI or clarify biological mechanisms driving symptoms. The announcement also highlights interest in studying chronic effects of neurotoxic exposures at doses comparable to what troops may have encountered during deployment, reflecting the view that long-term and latent consequences of exposures are central to the illness as experienced today.

The IIRA is structured to lower barriers for innovative early-stage concepts. Preliminary data are not required, which allows researchers to propose well-justified ideas that may be new to the GWI field. At the same time, applications without preliminary data still need a strong scientific rationale and can be grounded in clinical observations or in discoveries from related chronic multisymptom illnesses, as long as the proposed work is clearly translated back to GWI and Gulf War Veterans. This makes the mechanism suitable for exploratory but disciplined studies that test whether a promising concept is plausible in the GWI context.

For animal research, the opportunity is fairly prescriptive. Animal studies are expected to model long-term and latent effects of toxic exposures to mirror the current status of GWI patients decades after the war, not just short-term toxicity. The program discourages creating brand-new animal models; investigators are expected to use established models unless there is a compelling scientific reason to do otherwise. This reflects a preference for approaches that are more immediately interpretable and comparable across studies, rather than spending limited resources on model development.

Beyond biomarker discovery and mechanistic studies, the award also supports early translational development work tied to GWI-targeted interventions. This includes pharmacologic agent testing through absorption, distribution, metabolism, and excretion (ADME) studies, as well as toxicology work that can support Investigational New Drug (IND)-enabling pharmacology and toxicology packages. Preclinical development of non-pharmacological interventions is also allowable, which broadens the scope to include potential device-based, behavioral, or other non-drug approaches, provided they are clearly justified as relevant to GWI.

A notable FY2015 update is explicit guidance for applications proposing biomarker research, reflecting the challenges of finding reliable markers in a condition tied to exposures that occurred more than two decades earlier. Applicants are strongly encouraged to design biomarker studies in ways that address confounding factors common in legacy cohorts and archived materials. Recommended approaches include using pre-existing, well-characterized GWI patient samples with matched controls where storage and handling artifacts are understood and controlled; focusing on biomarker candidates already supported by peer-reviewed literature with plausible diagnostic utility (for example, markers related to neural inflammation, mitochondrial dysfunction, or hormonal imbalance); validating markers linked to Gulf War-specific exposures in a way that separates them from post-deployment life events; and identifying markers within clinically meaningful subgroups (either by shared symptom patterns or by known exposure histories). The guidance also stresses conceptual clarity: investigators should distinguish between biomarkers of exposure itself, biomarkers of biological effects caused by exposure, and biomarkers of GWI as a clinical syndrome. For exposure-related markers, applicants are expected to do a broad survey of available Gulf War exposure data. Importantly, deriving biomarker candidates primarily from animal models is stated to not meet the intent of the biomarker focus under this award, signaling a preference for human-relevant samples and data when the goal is diagnostic biomarker advancement.

Administratively, this FY2015 opportunity (Funding Opportunity Number W81XWH-15-GWIRP-IIRA) was offered as a grant or cooperative agreement within the science and technology / research and development category, with no cost sharing requirement and eligibility listed as unrestricted (open to any entity type, subject to any additional eligibility text in the full announcement). The program anticipated about 5 awards with an estimated total funding level of $3.6 million. The posting date was May 14, 2015, with an original and final closing date of October 29, 2015, and the opportunity archived on November 28, 2015. For access issues, the announcement directs applicants to the CDMRP Help Desk (301-682-5507).

Browse more opportunities from the same agency: Dept. of the Army USAMRAA

Browse more opportunities from the same category: Science and Technology and other Research and Development

Next opportunity: Evaluating Quality Metrics for Risk Based Surveillance of Drug Manufacturing Operations and Facilities (U01)

Previous opportunity: DoD Gulf War Illness Epidemiology Research Award

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for W81XWH 15 GWIRP IIRA

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (W81XWH 15 GWIRP IIRA) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "W81XWH 15 GWIRP IIRA", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.